Document:

EX-10.27

 Exhibit 10.27 

Power of Attorney 
 I, Hu Haiqing, with ID
number of 320102198102151619, being a shareholder of 80% of the equity (“My Equity”) of Jiandatong Health Technology (Beijing) Co., Ltd., hereby irrevocably authorize ShanghaiMed iKang, Inc. to exercise the following rights with respect to
My Equity within the term of this Power of Attorney: 
 ShanghaiMed iKang, Inc. is hereby authorized to act on my behalf as my sole and exclusive agent and
attorney with respect to all matters concerning My Equity, including but not limited to: 1) attending the shareholders’ meetings of Jiandatong Health Technology (Beijing) Co., Ltd.; 2) exercising all the shareholder’s rights and
shareholder’s voting right I am entitled to according to law and Articles of Association of Jiandatong Health Technology (Beijing) Co., Ltd., including but not limited to the sale or transfer or pledge or disposition of My Equity in part or in
whole; 3) receiving the dividend, bonus and any distribution attributable to the shareholder that I have declared; and 4) designating and appointing, as my authorized representative, the legal representative (CEO), general manager and other senior
management members of Jiandatong Health Technology (Beijing) Co., Ltd. 
 ShanghaiMed iKang, Inc. shall have the power and authority under this Power of
Attorney to execute the Transfer Contract(s) stipulated in Exclusive Option Contract (to which I am required to be a party) on my behalf, and to duly perform the Equity Pledge Contract and the Exclusive Option Contract to which I am a contracting
party, both of which were executed concurrently with this Power of Attorney. The exercise of these powers shall not impose any restrictions on this Power of Attorney. 

All the actions conducted by ShanghaiMed iKang, Inc. in relation to My Equity shall be deemed as my own actions, and all documents executed by ShanghaiMed
iKang, Inc. shall be deemed to be executed by myself. I hereby acknowledge those actions and documents. 
 ShanghaiMed iKang, Inc. is entitled to assign its
rights regarding the aforesaid matters to any other person or entity at its own discretion and without giving any prior notice to me or obtaining my consent. 

This Power of Attorney shall be irrevocable and continuously valid from the date of execution of this Power of Attorney, so long as I am a shareholder of
Jiandatong Health Technology (Beijing) Co., Ltd. 
 During the term of this Power of Attorney, I hereby waive all the rights associated with My Equity,
which have been entrusted to ShanghaiMed iKang, Inc. through this Power of Attorney, and shall not exercise such rights by myself. 
  

			
	Signed by:	 	/s/ Hu Haiqing
	Name:	 	Hu Haiqing
	Date:	 	December 30, 2013

 Strictly ConfidentialEX-10.28

 Exhibit 10.28 

Statement and Acknowledgment 

I, as the shareholder of the 20% equity interest in Jiandatong Health Technology (Beijing) Co., Ltd. (hereinafter referred to as
“Company”), hereby state and acknowledge that, in the event that Mr. Hu Haiqing transfers, in whole or in part, the 80% equity interest in the Company held by him to any third party, I agree to such equity transfer unconditionally,
waiver my right of first refusal with respect to such equity transfer, and agree to cooperate to go through the formalities in relation to such equity transfer. 

In the event that I transfer any of the equity interest held by me to the third party, I agree to cause such third party to comply with the
obligations under this statement. 
 It is hereby stated and acknowledged. 

 

			
		 	By: Ma Rui
		
	Signature:	 	/s/ Ma Rui
	
	December 30, 2013EX-4.2

 Exhibit 4.2 

OPOWER, INC. 
 SECOND
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 
 November 24, 2010 

 OPOWER, INC. 

SECOND AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

This Second Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of November 24, 2010, by
and among OPOWER, Inc., a Delaware corporation (the “Company”), the holders of Series A Preferred Stock and Series B Preferred Stock (the “Prior Investors”) and/or Series C Preferred Stock of the
Company listed on Exhibit A hereto, each of which is herein referred to as an “Investor,” and Daniel Yates and Alexander Laskey, each of whom is herein referred to as a “Founder.” 

RECITALS 
 A. The Company,
the Founders and the Prior Investors have previously entered into an Amended and Restated Investors’ Rights Agreement dated as of October 16, 2008 (the “Prior Rights Agreement”). 

B. The Company and certain of the Investors (the “Series C Investors”) have entered or will enter into a Series C
Preferred Stock Purchase Agreement (the “Purchase Agreement”) of even date herewith pursuant to which the Company desires to sell to the Series C Investors and the Series C Investors desire to purchase from the Company
shares of the Company’s Series C Preferred Stock (the “Series C Preferred Stock”) and the Founders desire to sell to certain of the Series C Investors and certain of the Series C Investors desire to purchase
from the Founders shares of the Company’s Series SC Preferred Stock. A condition to the Series C Investors’ obligations under the Purchase Agreement is that the Company, the Founders and the Investors enter into this Agreement in
order to provide the Investors and Founders with certain rights to register shares of the Company’s common stock (“Common Stock”), including Common Stock issuable upon conversion of the Series C Preferred Stock held by the
Investors and in order to provide the Investors with, among other rights, (i) certain rights to receive or inspect information pertaining to the Company, and (ii) a right of first offer with respect to certain issuances by the Company of
its securities. The Company, the Prior Investors and the Founders each desire to induce the Series C Investors to purchase shares of Series C Preferred Stock pursuant to the Purchase Agreement by agreeing to the terms and conditions set
forth herein. 
 C. The undersigned satisfy the requirements set forth in Section 3.4 of the Prior Rights Agreement for amendments
thereto, and desire to (i) amend and restate the Prior Rights Agreement in its entirety as set forth in this Agreement and (ii) waive any right of first offer under Section 2.3 of the Prior Rights Agreement in connection with the
sales of Series C Preferred Stock under the Purchase Agreement. 

 AGREEMENT 

The parties hereby agree as follows: 

1. Registration Rights. The Company and the Investors covenant and agree as follows: 

1.1 Definitions. For purposes of this Agreement: 

(a) The term “Exchange Act” means the Securities Exchange Act of 1934, as amended (and any successor thereto) and the rules
and regulations promulgated thereunder; 
 (b) The term “Form S-3” means such form under the Securities Act as in effect
on the date hereof or any successor form under the Securities Act that permits significant incorporation by reference of the Company’s subsequent public filings under the Exchange Act; 

(c) The term “Founders’ Stock” means the shares of Common Stock issued to the Founders; 

(d) The term “Holder” means any person owning or having the right to acquire Registrable Securities or any assignee thereof
in accordance with Section 1.12 of this Agreement; 
 (e) The term “Qualified IPO” means a firm commitment
underwritten public offering by the Company of shares of its Common Stock pursuant to a registration statement on Form S-l under the Securities Act of 1933, as amended, which results in aggregate cash
proceeds to the Company of $50,000,000 (net of underwriting discounts and commissions); 
 (f) The terms “register,”
“registered,” and “registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering of
effectiveness of such registration statement or document; 
 (g) The term “Registrable Securities” means (i) the
shares of Common Stock issuable or issued upon conversion of the Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock, other than shares for which registration rights have terminated pursuant to
Section 1.15 hereof, (ii) the shares of Founders’ Stock; provided, however, that for the purposes of Section 1.2, 1.4 or 1.13 the Founders’ Stock shall not be deemed Registrable Securities and the
Founders shall not be deemed Holders, and (iii) any other shares of Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend or other distribution
with respect to, or in exchange for or in replacement of, the shares listed in (i) and (ii); provided, however, that the foregoing definition shall exclude in all cases any Registrable Securities sold by a person or entity
in a transaction in which his, her or its rights under this Agreement are not assigned pursuant to Section 1.12. Notwithstanding the foregoing, Common Stock or other securities shall only be treated as Registrable Securities if and so long as
(A) they have not been sold to or through a broker or dealer or underwriter in a public distribution or a public securities transaction, (B) they have not been sold in a transaction exempt from the registration and prospectus delivery
requirements of the Securities Act under Section 4(1) thereof so that all transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the consummation of such sale, or (C) the Holder thereof is entitled to
exercise any right provided in Section 1 in accordance with Section 1.15 below; 

  
 2 

 (h) The number of shares of “Registrable Securities then outstanding” shall be
determined by the number of shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities which are, Registrable Securities; 

(i) The term “SEC” means the Securities and Exchange Commission; and 

(j) The term “Securities Act” means the Securities Act of 1933, as amended (and any successor thereto) and the rules and
regulations promulgated thereunder. 
 1.2 Request for Registration. 

(a) If the Company shall receive at any time after the earlier of (i) November 30, 2013 or (ii) six months after the effective
date of the first registration statement for a public offering of securities of the Company (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or
similar plan or a transaction pursuant to Rule 145 under the Securities Act), a written request from the Holders of a majority of the Registrable Securities then outstanding that the Company file a registration statement under the Securities
Act covering the registration of at least 30% of the Registrable Securities then outstanding (or a lesser percent if the anticipated aggregate offering price, net of underwriting discounts and commissions, would exceed $10,000,000), then the Company
shall, within 10 days of the receipt thereof, give written notice of such request to all Holders and shall, subject to the limitations of subsection 1.2(b), use its best efforts to file as soon as practicable, and in any event within 90 days of
the receipt of such request, a registration statement under the Securities Act covering all Registrable Securities which the Holders request to be registered within 20 days of the mailing of such notice by the Company. 

(b) If the Holders initiating the registration request hereunder (“Initiating Holders”) intend to distribute the Registrable
Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 1.2 and the Company shall include such information in the written notice referred to in
subsection 1.2(a). The underwriter will be selected by a majority in interest of the Initiating Holders and shall be reasonably acceptable to the Company. In such event, the right of any Holder to include Registrable Securities in such
registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the
Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in subsection 1.5(e)) enter into an underwriting
agreement in customary form with the underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of this Section 1.2, if the underwriter advises the Initiating Holders in writing that marketing factors
require a limitation of the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities which would otherwise be underwritten pursuant hereto, and the number of shares of Registrable
Securities that may be included in the underwriting shall be allocated among all participating Holders thereof, including the Initiating 

  
 3 

 
Holders, in proportion (as nearly as practicable) to the amount of Registrable Securities of the Company owned by each participating Holder; provided, however, that the number of
shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. 

(c) Notwithstanding the foregoing, if the Company shall furnish to Holders requesting a registration statement pursuant to this
Section 1.2, a certificate signed by the President of the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its holders of capital stock for such
registration statement to be filed and it is therefore essential to defer the filing of such registration statement, the Company shall have the right to defer such filing for a period of not more than 120 days after receipt of the request of the
Initiating Holders; provided, however, that the Company may not utilize this right more than once in any twelve-month period. 

(d) In addition, the Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to this
Section 1.2: 
 (i) After the Company has effected three (3) registrations pursuant to this Section 1.2 and such
registrations have been declared or ordered effective; 
 (ii) During the period starting with the date 90 days prior to the Company’s
good faith estimate of the date of filing of, and ending on a date 90 days after the effective date of, a registration subject to Section 1.3 hereof unless such offering is the initial public offering of the Company’s securities, in which
case, ending on a date 180 days after the effective date of such registration subject to Section 1.3 hereof; provided that the Company is actively employing in good faith all reasonable efforts to cause such registration statement to
become effective; or 
 (iii) If the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately
registered on Form S-3 pursuant to a request made pursuant to Section 1.4 below. 
 1.3 Company Registration. If
(but without any obligation to do so) the Company proposes to register (including for this purpose a registration effected by the Company for holders of capital stock other than the Holders) any of its stock under the Securities Act in connection
with the public offering of such securities solely for cash (other than a registration relating solely to the sale of securities to participants in a Company stock plan or a transaction covered by Rule 145 under the Securities Act, a
registration in which the only stock being registered is Common Stock issuable upon conversion of debt securities which are also being registered, or any registration on any form which does not include substantially the same information as would be
required to be included in a registration statement covering the sale of the Registrable Securities), the Company shall, at such time, promptly give each Holder written notice of such registration. Upon the written request of each Holder given
within 20 days after mailing of such notice by the Company in accordance with Section 3.5, the Company shall, subject to the provisions of Section 1.8, cause to be registered under the Securities Act all of the Registrable Securities that
each such Holder has requested to be registered. 

  
 4 

 1.4 Form S-3 Registration. In case the Company shall receive from any Holder
or Holders of not less than 10% of the Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance
with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company will: 
 (a) promptly give written
notice of the proposed registration, and any related qualification or compliance, to all other Holders; and 
 (b) as soon as practicable,
effect such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities as are
specified in such request, together with all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within 15 days after receipt of such written notice from
the Company; provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 1.4: (i) if Form S-3
is not available for such offering by the Holders; (ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other
securities (if any) at an aggregate price to the public (net of any underwriters’ discounts or commissions) of less than $2,000,000; (iii) if the Company shall furnish to the Holders a certificate signed by the President of the Company
stating that in the good faith judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its holders of capital stock for such Form S-3 Registration to be
effected at such time, in which event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not more than 120 days after receipt of the request of the
Holder or Holders under this Section 1.4; provided, however, that the Company shall not utilize this right more than once in any 12-month period; (iv) if the Company has, within the 12-month period preceding the date
of such request, already effected two registrations on Form S-3 for the Holders pursuant to this Section 1.4; (v) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general
consent to service of process in effecting such registration, qualification or compliance; or (vi) during the period ending 180 days after the effective date of a registration statement subject to Section 1.3. 

(c) Subject to the foregoing, the Company shall file a registration statement covering the Registrable Securities and other securities so
requested to be registered as soon as practicable after receipt of the request or requests of the Holders. Registrations effected pursuant to this Section 1.4 shall not be counted as demands for registration or registrations effected pursuant
to Sections 1.2 or 1.3, respectively. 
 1.5 Obligations of the Company. Whenever required under this
Section 1 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a)
Prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the
Registrable Securities 

  
 5 

 
registered thereunder, keep such registration statement effective for up to 120 days, or until the distribution described in such registration statement is completed, if earlier. The Company
shall not be required to file, cause to become effective or maintain the effectiveness of any registration statement that contemplates a distribution of securities on a delayed or continuous basis pursuant to Rule 415 under the Securities Act.

 (b) Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement for up to 120 days, or until the distribution described
in such registration statement is completed, if earlier. 
 (c) Furnish to the Holders such numbers of copies of a prospectus, including a
preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 

(d) Use its best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue
Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions. 
 (e) In the event of any underwritten public offering, enter into and perform its
obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 

(f) Notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is
required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a
material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and, at the request of any such Holder, the Company will, as soon as reasonably practicable, file
and furnish to all such Holders a supplement or amendment to such prospectus (to the extent prepared by or on behalf of the Company) so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain
an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading in light of the circumstances under which they were made. 

(g) Cause all such Registrable Securities registered pursuant hereunder to be listed on each securities exchange on which similar securities
issued by the Company are then listed. 

  
 6 

 (h) Provide a transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

(i) Use its best efforts to furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to this
Section 1, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a registration pursuant to this Section 1, if such securities are being sold through underwriters, (i) an opinion,
dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters and (ii) a letter
dated such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the
underwriters. 
 1.6 Furnish Information. It shall be a condition precedent to the obligations of the Company to take
any action pursuant to this Section 1 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended
method of disposition of such securities as shall be required to effect the registration of such Holder’s Registrable Securities. The Company shall have no obligation with respect to any registration requested pursuant to Section 1.2 or
Section 1.4 of this Agreement if, as a result of the application of the preceding sentence, the number of shares or the anticipated aggregate offering price of the Registrable Securities to be included in the registration does not equal or
exceed the number of shares or the anticipated aggregate offering price required to originally trigger the Company’s obligation to initiate such registration as specified in subsection 1.2(a) or subsection 1.4(b)(2), whichever is
applicable. 
 1.7 Expenses of Registration. 

(a) Demand Registration. All expenses other than underwriting discounts and commissions incurred in connection with
registrations, filings or qualifications pursuant to Section 1.2, including (without limitation) all registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company, and the
reasonable fees and disbursements of one counsel for the selling Holders selected by them with the approval of the Company, which approval shall not be unreasonably withheld, shall be borne by the Company; provided, however,
that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 1.2 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable
Securities to be registered (in which case all participating Holders shall bear such expenses), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 1.2. 

(b) Company Registration. All expenses other than underwriting discounts and commissions incurred in connection with
registrations, filings or qualifications of Registrable Securities pursuant to Section 1.3 for each Holder (which right may be assigned as provided in Section 1.12), including (without limitation) all registration, filing, and
qualification 

  
 7 

 
fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling Holder or Holders selected by
them with the approval of the Company, which approval shall not be unreasonably withheld, shall be borne by the Company. 
 (c)
Registration on Form S-3. All expenses incurred in connection with a registration requested pursuant to Section 1.4, including (without limitation) all registration, filing, qualification, printers’ and accounting fees and
the reasonable fees and disbursements of one counsel for the selling Holder or Holders selected by them with the approval of the Company, which approval shall not be unreasonably withheld, and counsel for the Company, and any underwriters’
discounts or commissions associated with Registrable Securities, shall be borne by the Company. 
 1.8 Underwriting
Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock, the Company shall not be required under Section 1.3 to include any of the Holders’ securities in such
underwriting unless they accept the terms of the underwriting as agreed upon between the Company and the underwriters selected by it (or by other persons entitled to select the underwriters), and then only in such quantity as the underwriters
determine in their sole discretion will not jeopardize the success of the offering by the Company. If the total amount of securities, including Registrable Securities, requested by holders of capital stock to be included in such offering exceeds the
amount of securities sold other than by the Company that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such
securities, including Registrable Securities, which the underwriters determine in their sole discretion will not jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling security holders
according to the total amount of securities entitled to be included therein owned by each selling security holder or in such other proportions as shall mutually be agreed to by such selling security holders) but in no event shall (i) the amount
of securities of the selling Holders included in the offering be reduced below 25% of the total amount of securities included in such offering, unless such offering is the initial public offering of the Company’s securities, in which case, the
selling security holders may be excluded if the underwriters make the determination described above and no other holder’s securities are included or (ii) any securities held by a Founder be included if any securities held by any selling
Holder that is not also a Founder are excluded. For purposes of the preceding parenthetical concerning apportionment, for any selling security holder which is a holder of Registrable Securities and which is a partnership or corporation, the
partners, retired partners and holders of capital stock of such holder, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single
“selling security holder,” and any pro-rata reduction with respect to such “selling security holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals
included in such “selling security holder,” as defined in this sentence. 
 1.9 Delay of Registration. No
Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

  
 8 

 1.10 Indemnification. In the event any Registrable Securities are included
in a registration statement under this Section 1: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless
each Holder, the partners, members, officers, directors and stockholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such
Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other federal
or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”): (i) any
untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or
alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any
state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law; and the Company will pay to each such Holder, underwriter or controlling person, as incurred, any legal or other
expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 1.10(a)
shall not apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable
to any Holder, underwriter or controlling person for any such loss, claim, damage, liability, or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information
furnished expressly for use in connection with such registration by any such Holder, underwriter or controlling person. 
 (b) To the
extent permitted by law, each selling Holder, severally and not jointly, will indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the
Company within the meaning of the Securities Act, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages, or
liabilities (joint or several) to which any of the foregoing persons may become subject, under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect
thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in
connection with such registration; and each such Holder will pay, as incurred, any legal or other expenses reasonably incurred by any person intended to be indemnified pursuant to this subsection 1.10(b), in connection with investigating or
defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 1.10(b) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided, that in no event shall any indemnity under this subsection 1.10(b) exceed the net
proceeds from the offering received by such Holder, except in the case of willful fraud by such Holder. 

  
 9 

 (c) Promptly after receipt by an indemnified party under this Section 1.10 of notice of the
commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.10, deliver to the indemnifying party a written notice
of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with
counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties which may be represented without conflict by one counsel) shall have the right to retain one
separate counsel, with the reasonable fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing
interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if
prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 1.10, but the omission so to deliver written notice to the indemnifying party will not relieve
it of any liability that it may have to any indemnified party otherwise than under this Section 1.10. 
 (d) If the indemnification
provided for in this Section 1.10 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of
indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault
of the indemnifying party on the one hand and of the indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable
considerations; provided, that in no event shall any contribution by a Holder under this subsection 1.10(d), when combined with the amounts paid or payable by such Holder pursuant to subsection 1.10(b), exceed the net proceeds from
the offering received by such Holder, except in the case of willful fraud by such Holder. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and
opportunity to correct or prevent such statement or omission. 
 (e) Notwithstanding the foregoing, to the extent that the provisions on
indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

  
 10 

 (f) The obligations of the Company and Holders under this Section 1.10 shall survive the
completion of any offering of Registrable Securities in a registration statement under this Section 1, and otherwise. 
 1.11
Reports Under the Exchange Act. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Securities Act and any other rule or regulation of the SEC that may at any time permit a Holder
to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 

(a) make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act, at all
times after 90 days after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public so long as the Company remains subject to the periodic reporting requirements under
Sections 13 or 15(d) of the Exchange Act; 
 (b) take such action, including the voluntary registration of its Common Stock under
Section 12 of the Exchange Act, as is necessary to enable the Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end of
the fiscal year in which the first registration statement filed by the Company for the offering of its securities to the general public is declared effective; 

(c) file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act; and 
 (d) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) a written
statement by the Company that it has complied with the reporting requirements of Rule 144 under the Securities Act (at any time after 90 days after the effective date of the first registration statement filed by the Company), the Securities Act
and the Exchange Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after
it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Holder
of any rule or regulation of the SEC which permits the selling of any such securities without registration or pursuant to such form. 
 1.12
Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this Section 1 may be assigned (but only with all related obligations) by a Holder to a transferee or
assignee (i) of at least 200,000 shares of such securities (subject to adjustment for stock splits, stock dividends, reclassification or the like) (or if the transferring Holder owns less than 200,000 shares of such securities, then all
Registrable Securities held by the transferring Holder), (ii) that is a subsidiary, parent, partner, limited partner, retired partner, member, retired member or holder of capital stock of a Holder, (iii) that is an affiliated fund or
entity of the Holder, which means with respect to a limited liability company or a limited liability partnership, a fund or entity managed by the same manager or managing member or general partner or management company or by an entity controlling,
controlled by, or under common control with such manager or managing member or general 

  
 11 

 
partner or management company (such a fund or entity, an “Affiliated Fund”), (iv) who is a Holder’s child, stepchild, grandchild, parent, stepparent, grandparent,
spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (such a relation, a Holder’s “Immediate Family Member”, which term shall include adoptive relationships), or
(v) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member; provided the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of
such transferee or assignee and the securities with respect to which such registration rights are being assigned; and provided, further, that such assignment shall be effective only if the transferee agrees to be bound by this
Agreement and immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Securities Act. For the purposes of determining the number of shares of Registrable Securities held by
a transferee or assignee, the holdings of transferees and assignees of (x) a partnership who are partners or retired partners of such partnership or (y) a limited liability company who are members or retired members of such limited
liability company (including Immediate Family Members of such partners or members who acquire Registrable Securities by gift, will or intestate succession) shall be aggregated together and with the partnership or limited liability company;
provided that all assignees and transferees who would not qualify individually for assignment of registration rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices or taking any action under
Section 1. 
 1.13 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the
Company shall not, without the prior written consent of the Holders of a majority of the outstanding Registrable Securities, enter into any agreement with any holder or prospective holder of any securities of the Company which would allow such
holder or prospective holder (a) to include such securities in any registration filed under Section 1.2 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities in any such
registration only to the extent that the inclusion of his securities will not reduce the amount of the Registrable Securities of the Holders which is included or (b) to make a demand registration which could result in such registration
statement being declared effective prior to the earlier of either of the dates set forth in subsection 1.2(a) or within 120 days of the effective date of any registration effected pursuant to Section 1.2. 

1.14 Lock-Up Agreement. 

(a) Lock-Up Period; Agreement. In connection with the initial public offering of the Company’s securities and upon request
of the Company or the underwriters managing such offering of the Company’s securities, each Holder agrees not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the Company,
however or whenever acquired (other than those included in the registration) without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed one hundred eighty (180) days plus an
additional 34 days as may be required to comply with applicable regulation, following the effective date of any underwritten registration statement of the Company filed under the Securities Act) from the effective date of such registration as
may be requested by the Company or such managing underwriters and to execute an agreement reflecting the foregoing as may be requested by the underwriters at the time of the Company’s initial public offering. The foregoing provisions of
Section 1.14 shall not apply to any sale of any shares pursuant to an underwriting agreement. 

  
 12 

 
Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in the Company’s initial public offering that are consistent with this
Section 1.14 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply to all Holders subject to such
agreements pro rata based on the number of shares subject to such agreements. 
 (b) Limitations. The obligations described
in Section 1.14(a) shall apply only if all officers, directors and 1% securityholders of the Company enter into similar agreements, and shall not apply to a registration relating solely to employee benefit plans, or to a registration relating
solely to a transaction pursuant to Rule 145 under the Securities Act. 
 (c) Stop-Transfer Instructions. In order to
enforce the foregoing covenants, the Company may impose stop-transfer instructions with respect to the securities of each Holder (and the securities of every other person or entity subject to the restrictions in Section 1.14(a)). 

(d) Transferees Bound. Each Holder agrees that, prior to the Company’s initial public offering, it will not transfer
securities of the Company unless each transferee agrees in writing to be bound by all of the provisions of this Section 1.14. 
 1.15
Termination of Registration Rights. No Holder shall be entitled to exercise any right provided for in this Section 1 after the earlier of (i) two years following the consummation of a Qualified IPO, (ii) such time
as the Company’s Common Stock is publicly traded and Rule 144 or another similar exemption under the Securities Act is available for the sale of all of such Holder’s shares during a three-month period without registration, or
(iii) upon termination of the Agreement, as provided in Section 3.1. 
 2. Covenants of the Company. 

2.1 Delivery of Financial Statements. For so long as MHS Capital Partners, L.P. (“MHS Capital”) holds a
majority of the issued and outstanding Series A Preferred Stock, and so long as Puressence Limited (“Puressence”) and New Cycle Capital Partners, L.P. (“New Cycle”) hold at least 20% of the issued and
outstanding Series A Preferred Stock originally issued (or in the case of New Cycle, transferred) to them, and so long as New Enterprise Associates 12, Limited Partnership (“NEA”) holds greater than 50% of the issued and
outstanding Series B Preferred Stock, and so long as Accel X, L.P. (together with its affiliates, “Accel”) holds at least 50% of the issued and outstanding Series C Preferred Stock originally issued to them, and so
long as KPCB Holdings, Inc. (“KPCB”) holds at least 50% of the issued and outstanding Series C Preferred Stock originally issued to them, the Company shall deliver to each of NEA, Accel and KPCB, respectively, and, upon their
written request, each of MHS Capital, Puressence, New Cycle, respectively: 
 (a) as soon as practicable, but in any event within 90 days
after the end of each fiscal year of the Company, unless otherwise waived by the Company’s Board of Directors (the “Board”), an unaudited income statement for such fiscal year, an unaudited balance sheet of the Company and
statement of shareholders’ equity as of the end of such year, 

  
 13 

 
and an unaudited statement of cash flows for such year, such year-end financial reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles
(“GAAP”) consistently applied with prior practice for earlier periods (with the exception of footnotes that may be required by GAAP) and fairly present the financial condition of the Company and its results of operation for the
period(s) specified; provided that the foregoing shall not restrict the right of the Company to change its accounting principles consistent with GAAP, if the Board, including the director elected by the holders of a majority of the
Series A Preferred Stock (the “Series A Director”) and the director elected by the holders of a majority of the Series B Preferred Stock (the “Series B Director”), determines that it is in the
best interest of the Company to do so; 
 (b) as soon as practicable, but in any event within 45 days after the end of each of the first
three quarters of each fiscal year of the Company, unless otherwise waived by the Board, an unaudited profit or loss statement, a statement of cash flows for such fiscal quarter and an unaudited balance sheet as of the end of such fiscal quarter
prepared in accordance with GAAP consistently applied with prior practice for earlier periods (with the exception of footnotes that may be required by GAAP) and fairly present the financial condition of the Company and its results of operation for
the period(s) specified, subject to normal year-end audit adjustment; provided that the foregoing shall not restrict the right of the Company to change its accounting principles consistent with GAAP, if the Board of Directors, including the
Series A Director and the Series B Director, determines that it is in the best interest of the Company to do so; and 
 (c) as soon as
practicable, but in any event at least 30 days prior to the end of each fiscal year, unless otherwise waived by the Board, including the Series A Director and the Series B Director, a budget and business plan for the next fiscal year,
prepared on a monthly basis, and, as soon as prepared, any other budgets or revised budgets prepared by the Company. 
 2.2
Inspection. The Company shall permit each of NEA, MHS Capital, Puressence and New Cycle (each, an “Inspection Party”) (except for an Inspection Party reasonably deemed by the Company to be a competitor of the Company),
at such Inspection Party’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times
as may be requested by the Inspection Party; provided, however, that the Company shall not be obligated pursuant to this Section 2.2 to provide access to any information which it reasonably considers to be a trade secret or
similar confidential information (unless the Inspection Party enters into a confidentiality agreement in a form reasonably acceptable to the Company). 

2.3 Right of First Offer. Subject to the terms and conditions specified in this Section 2.3, the Company hereby grants to
the following “Pro Rata Holders” (i) NEA, (ii) MHS Capital, (iii) Accel, (iv) KPCB and (v) Thiry-O’Leary Living Trust Dated March 8, 1990, New Cycle, Puressence Limited and Pinky Swear Trust
(each such holder described in clause (v), a “Series A Pro Rata Holder, and together the “Series A Pro Rata Holders”) a right of first offer with respect to future sales by the Company of its Shares (as
hereinafter defined). For purposes of this Section 2.3, with the exception of Section 2.3(a), (w) NEA includes any general 

  
 14 

 
partners, managing members and affiliates of NEA, including Affiliated Funds (x) MHS Capital includes any general partners, managing members and affiliates of MHS Capital, including
Affiliated Funds, (y) Accel includes any general partners, managing members and affiliates of Accel, including Affiliated Funds and (z) KPCB includes any general partners, managing members and affiliates of KPCB, including Affiliated
Funds. If NEA, MHS Capital, Accel, KPCB or a Pro Rata Holder chooses to exercise the right of first offer, it may designate as purchasers under such right itself or its partners, members or affiliates, including Affiliated Funds, in such proportions
as it deems appropriate. 
 Each time the Company proposes to offer any shares of, or securities convertible into or exercisable for any
shares of, any class of its capital stock (“Shares”), the Company shall first make an offering of such Shares to the Pro Rata Holders in accordance with the following provisions: 

(a) The Company shall deliver a notice (the “RFO Notice”) to the Pro Rata Holders stating (i) its bona fide intention to
offer such Shares, (ii) the number of such Shares to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such Shares. 

(b) Within 15 calendar days after delivery of the RFO Notice: 

(i) NEA may elect to purchase or obtain, at the price and on the terms specified in the RFO Notice, up to that portion of such Shares which
equals the proportion that the number of shares of Common Stock issuable upon conversion of all Series B Preferred Stock bears to the sum of (A) total number of shares of Common Stock then outstanding (assuming full conversion and exercise
of all convertible or exercisable securities) and (B) shares of Common Stock issuable to employees, consultants or directors pursuant to a stock option plan, restricted stock plan, or other stock plan approved by the Board of Directors, and

 (ii) MHS Capital may elect to purchase or obtain, at the price and on the terms specified in the RFO Notice, up to that portion of such
Shares which equals 72.8% of the Series A Pro Rata (as defined below), and each Series A Pro Rata Holder may elect to purchase or obtain, at the price and on the terms specified in the RFO Notice, up to that portion of such Shares which equals
the proportion that the number of shares of Common Stock issuable upon conversion of all Series A Preferred Stock then held by such Series A Pro Rata Holder bears to the sum of (A) the total number of shares of Common Stock then
outstanding (assuming full conversion and exercise of all convertible or exercisable securities) and (B) shares of Common Stock issuable to employees, consultants or directors pursuant to a stock option plan, restricted stock plan, or other
stock plan approved by the Board of Directors. The “Series A Pro Rata” shall mean the proportion that the number of shares of Common Stock issuable upon conversion of all Series A Preferred Stock then held bears to the sum
of (A) total number of shares of Common Stock then outstanding (assuming full conversion and exercise of all convertible or exercisable securities) and (B) shares of Common Stock issuable to employees, consultants or directors pursuant to
a stock option plan, restricted stock plan, or other stock plan approved by the Board of Directors. 

  
 15 

 (iii) Accel and KPCB may each elect to purchase or obtain, at the price and on the terms
specified in the RFO Notice, up to that portion of such Shares which equals the proportion that the number of shares of Common Stock issuable upon conversion of all Series C Preferred Stock then held by such Investor bears to the sum of
(A) the total number of shares of Common Stock then outstanding (assuming full conversion and exercise of all convertible or exercisable securities) and (B) shares of Common Stock issuable to employees, consultants or directors pursuant to
a stock option plan, restricted stock plan, or other stock plan approved by the Board of Directors. Such purchase(s) under clauses (i), (ii) and (iii) shall be completed at the same closing as that of any third party purchasers or at
an additional closing thereunder. 
 (c) The Company may, during the 45-day period following the expiration of the period provided in
subsection 2.3(b) hereof, offer the remaining unsubscribed portion of the Shares to any person or persons at a price not less than, and upon terms no more favorable to the offeree than those specified in the RFO Notice. If the Company does not
enter into an agreement for the sale of the Shares within such period, or if such agreement is not consummated within 60 days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered
unless first reoffered to NEA, MHS Capital, Accel, KPCB and the Series A Pro Rata Holders in accordance herewith. 
 (d) The right of first
offer in this Section 2.3 shall not be applicable to (i) the issuance of securities excluded from the definition of Additional Stock as set forth in Article IV(B)(4)(d)(i)(B) of the Company’s Fourth Amended and Restated
Certificate of Incorporation, as the same may be amended or waived from time to time (the “Restated Charter”), and (ii) the issuance of Series C Preferred Stock and Series C Preferred Stock including without
limitation as a result of the transfer and conversion of shares of Series SC Preferred Stock. By executing this Agreement, NEA, MHS Capital and each Series A Pro Rata Holder hereby waives any right of first offer under Section 2.3 of the Prior
Rights Agreement in connection with the issuances of Series C Preferred Stock including without limitation as a result of the conversion of shares of Series SC Preferred Stock. In addition to the foregoing, the right of first offer in this
Section 2.3 shall not be applicable to NEA, MHS Capital, Accel, KPCB or any Series A Pro Rata Holder, respectively, if (i) at the time of such subsequent securities issuance, NEA, MHS Capital, Accel, KPCB or such Series A Pro Rata
Holder, respectively, is not an “accredited investor,” as that term is then defined in Rule 501(a) under the Securities Act, and (ii) such subsequent securities issuance is otherwise being offered only to accredited investors.

 2.4 Employee Agreements. The Company will cause each person now or hereafter employed by it or by any subsidiary (or
engaged by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights assignment agreement, substantially in the form
attached hereto as Exhibit B. In addition, the Company shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock agreement between the Company and
any employee, without the consent of the Board of Directors, NEA and MHS Capital. 

  
 16 

 2.5 Insurance. The Company shall use its commercially reasonable best
efforts to obtain within ninety (90) days of the date hereof, (i) general liability, (ii) casualty, (iii) employment practices, (iv) errors and omissions, and (v) directors and officers insurance policies in an amount
satisfactory to the Board of Directors and will use commercially reasonable best efforts to cause such insurance policies to be maintained. 

2.6 Termination of Covenants. 

(a) The covenants set forth in Sections 2.1 through 2.4 shall terminate as to each Holder and be of no further force or effect
(i) immediately prior to the consummation of a Qualified IPO, or (ii) upon termination of the Agreement, as provided in Section 3.1. 

(b) The covenants set forth in Sections 2.1 and 2.2 shall terminate as to each Holder and be of no further force or effect when the
Company first becomes subject to the periodic reporting requirements of Sections 13 or 15(d) of the Exchange Act, if this occurs earlier than the events described in subsection (a) immediately above. 

3. Miscellaneous. 

3.1 Termination. This Agreement shall terminate, and have no further force and effect, when the Company shall consummate
a transaction or series of related transactions deemed to be a liquidation, dissolution or winding up of the Company pursuant to the Restated Charter. 

3.2 Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto pertaining to the subject
matter hereof, and any and all other written or oral agreements relating to the subject matter hereof existing between the parties hereto are expressly canceled. 

3.3 Successors and Assigns. Except as otherwise provided in this Agreement, the terms and conditions of this Agreement shall
inure to the benefit of and be binding upon the respective permitted successors and assigns of the parties (including transferees of any of the Preferred Stock or any Common Stock issued upon conversion thereof). Nothing in this Agreement, express
or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this
Agreement. 
 3.4 Amendments and Waivers. Any term of this Agreement may be amended or waived only with the written consent of
the Company and the holders of a majority of the Registrable Securities then outstanding, not including the Founders’ Stock; provided, however, that if such amendment or waiver is with respect to Sections 1 or 3 and has the effect
of affecting the Founders’ Stock (i) in a manner different than securities issued to the Investors and (ii) in a manner adverse to the interests of the holders of the Founders’ Stock, then such amendment shall require the consent
of the holder or holders of a majority of the Founders’ Stock; provided, further, that except as set forth in subsection 2.3(d), the right of first offer set forth in Section 2.3 may not be waived or amended with respect
to any issuance of Shares without the written consent of the holders of a majority of the Registrable Securities then held by Pro Rata Holders not acquiring such Shares. Notwithstanding the foregoing, the Company may 

  
 17 

 
amend this Agreement solely to add a party, who after the date of this Agreement acquires shares of the Company’s Series C Preferred Stock pursuant to the terms of the Purchase
Agreement (including as contemplated by Section 6.18 thereof). Any such additional party, by executing a counterpart signature page to this Agreement, shall become an Investor for all purposes and shall be bound by all of the applicable
provisions under this Agreement. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each party to the Agreement, whether or not such party has signed such amendment or waiver, each future holder of all such
Registrable Securities, and the Company. 
 3.5 Notices. Unless otherwise provided, any notice required or permitted by
this Agreement shall be in writing and shall be deemed sufficient upon delivery, when delivered personally or by overnight courier or sent by facsimile, or 48 hours after being deposited in the U.S. mail, as certified or registered mail, with
postage prepaid, and addressed to the party to be notified at such party’s address or facsimile number as set forth on Exhibit A hereto or as subsequently modified by written notice. 

3.6 Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties
agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision shall be excluded from this Agreement, (b) the
balance of the Agreement shall be interpreted as if such provision were so excluded and (c) the balance of the Agreement shall be enforceable in accordance with its terms. 

3.7 Governing Law. This Agreement and all acts and transactions pursuant hereto shall be governed, construed and interpreted in
accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of laws. 
 3.8
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

3.9 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be
considered in construing or interpreting this Agreement. 
 3.10 Aggregation of Stock. All shares of the Preferred Stock held
or acquired by affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 

3.11 Amendment and Restatement of Prior Rights Agreement. The Prior Rights Agreement is hereby amended and restated in its
entirety as set forth in this Agreement and is of no further force or effect. 
 [Signature Page Follows] 

  
 18 

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	 THE COMPANY:
  

OPOWER, INC.

		
	By:	 	/s/ Daniel Yates
		 	(Signature)
	
	Name: Daniel Yates
	Title: Chief Executive Officer
	
	 Address:
 1515 N Courthouse Road,
Suite 610
 Arlington VA 22201

	
	 THE FOUNDERS:
  

DANIEL YATES

	
	/s/ Daniel Yates
	(Signature)
	
	 Address:
 1515 N Courthouse Road,
Suite 610
 Arlington VA 22201

	
	 ALEXANDER LASKEY

	
	/s/ Alexander Laskey
	(Signature)
	
	 Address:
 1515 N Courthouse Road,
Suite 610
 Arlington VA 22201

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	 THE INVESTORS:
  

Accel X L.P.

		
	By:	 	Accel X Associates L.L.C.
	
	Its General Partner
		
	By:	 	/s/ Illegible
	Attorney in Fact
	
	Accel X Strategic Partners L.P.
		
	By:	 	Accel X Associates L.L.C.
	
	Its General Partner
		
	By:	 	/s/ Illegible
	Attorney in Fact
	
	Accel Investors 2010 L.L.C.
		
	By:	 	/s/ Illegible
	Attorney in Fact
	
	Addresses for notices:
	
	 J. Peter Wagner
 Rich Zamboldi

Accel Partners
 428 University Avenue

Palo Alto, CA 94301

(            )
            -            - Tel.

(            )
            -            – Fax

[redacted]@accel.com
 [redacted]@accel.com

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	 THE INVESTORS:
  

KPCB Holdings, Inc., as nominee

		
	By:	 	/s/ Illegible
	Its:	 	President
	
	 Address:
 2750 Sand Hill Road

Menlo Park, CA 94025

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	 THE INVESTORS:
  

New Enterprise Associates 12, Limited Partnership

	
	By: NEA Partners 12, Limited Partnership, its general partner
		
	By:	 	NEA 12 GP, LLC, its general partner
		
	By:	 	/s/ Illegible                        , General Counsel
	
	NEA Ventures 2008, Limited Partnership
		
	By:	 	/s/ Illegible                                , Vice
President
	
	 Address:
 1954 Greenspring Drive,
Suite 600
 Timonium, MD 21093-4135

	
	 Telephone: (            )
            -            

Fax: (            )
            -            

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	 THE INVESTORS:
  

MHS CAPITAL PARTNERS, L.P.

		
	By:	 	/s/ Mark Sugarman
		 	(Signature)
	Name: Mark Sugarman
	Title: GP 
	
	 Address:
 C/O ITN

1 Market Street
 Steuart tower suite 1010

SF, CA 94105

	
	 Phone: (            )
            -            

Fax: (            )
            -            

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	THE INVESTORS:
	
	MHS CAPITAL PRINCIPALS FUND
		
	By:	 	/s/ Mark Sugarman
		 	(Signature)
	
	Name: Mark Sugarman
	Title: Managing Member
	
	 Address:
 C/O ITN

1 Market Street
 Steuart tower suite 1010

SF, CA 94105

	
	 Phone: (        )
        -            
 Fax:
(        )         -            

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	THE INVESTORS:
	
	NEW CYCLE CAPITAL PARTNERS, L.P.
		
	By:	 	 NEW CYCLE CAPITAL, L.P.
 General
Partner

		
	By:	 	 NCC MANAGEMENT, LLC
 General
Partner

		
	By:	 	/s/ Benjamin D. Black
		 	(Signature)
	
	Benjamin D. Black, Managing Member
	
	 Address:
 410 Jessie Street, Suite
501
 San Francisco, CA 941031

	
	 Email: [redacted]@newcyclecapital.com

Phone: (        )
        -            

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	THE INVESTORS:
	
	PURESSENCE LIMITED
		
	By:	 	/s/ Illegible
		 	(Signature)
	
	Name: For: Chaumont (Directors) Limited
	Title: Corporate Director
	
	 Address:
 Sir Walter Raleigh
House
 48/50 Esplanade
 St Helier

Jersey
 JE1 4HH

Channel Islands

	
	Phone: +44         -            
	
	Fax: +44         -            
	
	25/11/2010

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	THE INVESTORS:
	
	PINKY SWEAR TRUST
		
	By:	 	/s/ Hadi Partovi
		 	(Signature)
	
	Name: Hadi Partovi
	Title: Trustee
	
	Address: [Redacted]
	
	Phone: (        )
        -            
	
	Fax: (        )
        -            

 The parties have executed this Second Amended and Restated Investors’ Rights Agreement of
OPOWER, Inc. as of the date first above written. 
  

			
	THE INVESTORS:
	
	THIRY-O’LEARY LIVING TRUST DATED MARCH 8, 1990
		
	By:	 	/s/ Denise M. O’Leary, /s/ Kent J. Thiry
		 	(Signature)
	
	Name: Denise M. O’Leary, Kent J. Thiry
	Title: Trustees
	
	 Address:
 [Redacted]

	
	Telephone: (        )         -            
	
	Fax: (        )         -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]